Cargando…

Downregulation of N-myc and STAT Interactor Protein Predicts Aggressive Tumor Behavior and Poor Prognosis in Invasive Ductal Carcinoma

PURPOSE: We investigated the expression of the N-myc and STAT interactor (NMI) protein in invasive ductal carcinoma tissue and estimated its clinicopathologic significance as a prognostic factor. The expression levels and prognostic significance of NMI were also analyzed according to the molecular s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ji Eun, Hyun, Chang Lim, Jin, Min-Sun, Lee, Kyung-min, Moon, Ji Hye, Ryu, Han Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043944/ https://www.ncbi.nlm.nih.gov/pubmed/32140268 http://dx.doi.org/10.4048/jbc.2020.23.e12

Ejemplares similares

High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma
por: Meng, Delong, et al.
Publicado: (2014)

Roles of N‐Myc and STAT interactor in cancer: From initiation to dissemination
por: Pruitt, Hawley C., et al.
Publicado: (2016)

N‐myc and STAT interactor correlates with severity and prognosis in acute‐on‐chronic liver failure of hepatitis B virus
por: Xiong, Lifu, et al.
Publicado: (2019)

The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas
por: Jang, Se Min, et al.
Publicado: (2012)

N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells
por: Metge, Brandon J., et al.
Publicado: (2015)

Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor
por: Cheng, Weijia, et al.
Publicado: (2015)

N-myc and STAT interactor is a novel biomarker of severity in community-acquired pneumonia: a prospective study
por: Zhang, Wanying, et al.
Publicado: (2022)

Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors
por: Pruitt, Hawley C., et al.
Publicado: (2018)

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018)

MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
por: Farrell, Amy S., et al.
Publicado: (2017)

microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer
por: Rostas, Jack W, et al.
Publicado: (2014)

Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness
por: Grandits, Alexander Michael, et al.
Publicado: (2021)

Loss of N-Myc interactor promotes epithelial-mesenchymal-transition by activation of TGF-β/SMAD signaling
por: Devine, Daniel J., et al.
Publicado: (2013)

Dedifferentiated Endometrioid Adenocarcinoma of the Uterus: Highly Aggressive and Poor Prognostic Tumor
por: Park, Shin Young, et al.
Publicado: (2014)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation
por: Hirabayashi, Kenichi, et al.
Publicado: (2022)

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
por: Kim, Jongmin, et al.
Publicado: (2009)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR/Stat3-Mediated c-Myc Downregulation
por: Kim, Ji-Hyang, et al.
Publicado: (2021)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Downregulation of osteoprotegerin expression in metastatic colorectal carcinoma predicts recurrent metastasis and poor prognosis
por: Moon, Ahrim, et al.
Publicado: (2016)

Expression of pAkt is associated with a poor prognosis in Chinese women with invasive ductal breast cancer
por: Zhou, Ling, et al.
Publicado: (2018)

Rap GTPase Interactor: A Potential Marker for Cancer Prognosis Following Kidney Transplantation
por: Fu, Qiang, et al.
Publicado: (2019)

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
por: He, Jun, et al.
Publicado: (2016)

Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma
por: He, Lin, et al.
Publicado: (2019)

Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer
por: Wang, Ya-Juan, et al.
Publicado: (2022)

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer
por: Schulze, Amy, et al.
Publicado: (2020)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma
por: Zhao, Yu, et al.
Publicado: (2016)

Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma
por: Yan, Ting-Ting, et al.
Publicado: (2015)

Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients
por: Wang, Pu-Ning, et al.
Publicado: (2017)

Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma
por: Wu, Moxin, et al.
Publicado: (2020)

Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma
por: Lu, Yao, et al.
Publicado: (2018)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients
por: Yan, Shushan, et al.
Publicado: (2017)

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
por: Ralhan, Ranju, et al.
Publicado: (2010)

MYC is downregulated by a mitochondrial checkpoint mechanism
por: Zhang, Xiaonan, et al.
Publicado: (2017)

Regulation of cytohesins by their interactors in the nervous system
por: Zhai, Yuqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hl2sqsd399s8b71knjr39a41bp